ORSHINA

Welcome to the Brand page for “ORSHINA”, which is offered here for Scientific research and laboratory apparatus; apparatus for drug discovery; apparatus for drug development;pharmaceuticals, in particular pharmaceuticals for treating fibrosis, pharmaceuticals for treating lung diseases, pharmaceuticals for treating inflammatory disorders, pharmaceuticals for treating scars and scar formation, pharmaceuticals for promoting tissue repair and/or tissue regeneration, pharmaceuticals for wound healing, wherein all aforementioned pharmaceuticals include small chemical molecules, peptides, proteins, nucleic acids, cellular products and gene therapy products; diagnostic reagents, for medical and veterinary purposes;chemicals for use in industry and science, in particular reagents for labelling of biomolecules, reagents for tagging of biomolecules; reagents for visualization or detection of biomolecules; reagents for tagging of chemical entities or chemical molecules; reagents for generation of molecular constructs, transfection reagents, reagents for gene editing; reagents for investigations in relation to tissue disorders; reagents for investigations in relation to fibrosis; reagents for investigations in relation to inflammatory disorders; diagnostic reagents, not for medical or veterinary purposes; chemical reagent mixtures in kit form, other than for medical or veterinary use; kits comprising reagents for use in scientific research, in particular kits for labelling of biomolecules; kits for tagging of biomolecules comprising reagents for tagging of biomolecules; kits for visualization or detection of biomolecules comprising reagents for visualization or detection of biomolecules; kits for generation of molecular constructs comprising reagents for generation of molecular constructs; transfection kits comprising reagents for transfection of cells; kits for gene editing comprising reagents for gene editing; kits for investigations in relation to tissue disorders comprising reagents for investigations in relation to tissue disorders; kits for investigations in relation to fibrosis comprising reagents for investigations of fibrosis; kits for investigations in relation to inflammatory disorders comprising reagents for investigations of inflammatory disorders; diagnostic kits not for medical and veterinary purposes;diagnosis and treatment of fibrosis, lung diseases, or scars or scar formation; diagnosis and healing of wound; promotion of tissue repair and/or tissue regeneration for treatment of inflammatory conditions; treatment prediction and diagnostics in the field of medicine and veterinary medicine;scientific and industrial research in particular in the biochemical, diagnostic or pharmaceutical fields; biochemical or pharmaceutical laboratory services, in particular in the field of discovery and development of drugs for treating fibrosis, lung diseases, or scars, drugs for preventing scar formation or drugs for wound healing, in the field of discovery of drugs for promoting tissue repair and/or tissue regeneration; analysis of active ingredients in the field of drugs for treating fibrosis, lung diseases, or scars, or in the field of drugs for preventing scar formation or drugs for wound healing, or in the field of drugs for promoting tissue repair and/or tissue regeneration; scientific consultancy, in particular with respect to drug discovery methodologies and systems for drug discovery and with respect to drug development methodologies and systems for drug development;.

Its status is currently believed to be active. Its class is unavailable. “ORSHINA” is believed to be currently owned by “Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt(GmbH)”.